SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling

The metabolic enzymes involved in one-carbon metabolism are closely associated with tumor progression and could be potential targets for cancer therapy. Recent studies showed that serine hydroxymethyltransferase 2 (SHMT2), a crucial enzyme in the one-carbon metabolic pathway, plays a key role in tum...

Full description

Bibliographic Details
Main Authors: Weida Wang, Mingjin Wang, Tingting Du, Zhenyan Hou, Shen You, Sen Zhang, Ming Ji, Nina Xue, Xiaoguang Chen
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/8/7150
_version_ 1797605189568430080
author Weida Wang
Mingjin Wang
Tingting Du
Zhenyan Hou
Shen You
Sen Zhang
Ming Ji
Nina Xue
Xiaoguang Chen
author_facet Weida Wang
Mingjin Wang
Tingting Du
Zhenyan Hou
Shen You
Sen Zhang
Ming Ji
Nina Xue
Xiaoguang Chen
author_sort Weida Wang
collection DOAJ
description The metabolic enzymes involved in one-carbon metabolism are closely associated with tumor progression and could be potential targets for cancer therapy. Recent studies showed that serine hydroxymethyltransferase 2 (SHMT2), a crucial enzyme in the one-carbon metabolic pathway, plays a key role in tumor proliferation and development. However, the precise role and function of SHMT2 in gastric cancer (GC) remain poorly understood. In this study, we presented evidence that SHMT2 was necessary for hypoxia-inducible factor-1α (HIF1α) stability and contributed to GC cells’ hypoxic adaptation. The analysis of datasets retrieved from The Cancer Genome Atlas and the experimentation with human cell lines revealed a marked increase in SHMT2 expression in GC. The SHMT2 knockdown in MGC803, SGC7901, and HGC27 cell lines inhibited cell proliferation, colony formation, invasion, and migration. Notably, SHMT2 depletion disrupted redox homeostasis and caused glycolytic function loss in GC cells under hypoxic circumstances. Mechanistically, we discovered SHMT2 modulated HIF1α stability, which acted as a master regulator of hypoxia-inducible genes under hypoxic conditions. This, in turn, regulated the downstream VEGF and STAT3 pathways. The in vivo xenograft experiments showed that SHMT2 knockdown markedly reduced GC growth. Our results elucidate the novel function of SHMT2 in stabilizing HIF1α under hypoxic conditions, thus providing a potential therapeutic strategy for GC treatment.
first_indexed 2024-03-11T04:57:35Z
format Article
id doaj.art-e3db007ee5e04c96ad2600bb6e145fe1
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T04:57:35Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-e3db007ee5e04c96ad2600bb6e145fe12023-11-17T19:35:59ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-04-01248715010.3390/ijms24087150SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 SignalingWeida Wang0Mingjin Wang1Tingting Du2Zhenyan Hou3Shen You4Sen Zhang5Ming Ji6Nina Xue7Xiaoguang Chen8Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaThe metabolic enzymes involved in one-carbon metabolism are closely associated with tumor progression and could be potential targets for cancer therapy. Recent studies showed that serine hydroxymethyltransferase 2 (SHMT2), a crucial enzyme in the one-carbon metabolic pathway, plays a key role in tumor proliferation and development. However, the precise role and function of SHMT2 in gastric cancer (GC) remain poorly understood. In this study, we presented evidence that SHMT2 was necessary for hypoxia-inducible factor-1α (HIF1α) stability and contributed to GC cells’ hypoxic adaptation. The analysis of datasets retrieved from The Cancer Genome Atlas and the experimentation with human cell lines revealed a marked increase in SHMT2 expression in GC. The SHMT2 knockdown in MGC803, SGC7901, and HGC27 cell lines inhibited cell proliferation, colony formation, invasion, and migration. Notably, SHMT2 depletion disrupted redox homeostasis and caused glycolytic function loss in GC cells under hypoxic circumstances. Mechanistically, we discovered SHMT2 modulated HIF1α stability, which acted as a master regulator of hypoxia-inducible genes under hypoxic conditions. This, in turn, regulated the downstream VEGF and STAT3 pathways. The in vivo xenograft experiments showed that SHMT2 knockdown markedly reduced GC growth. Our results elucidate the novel function of SHMT2 in stabilizing HIF1α under hypoxic conditions, thus providing a potential therapeutic strategy for GC treatment.https://www.mdpi.com/1422-0067/24/8/7150gastric cancerSHMT2HIF1αredox balanceprogression
spellingShingle Weida Wang
Mingjin Wang
Tingting Du
Zhenyan Hou
Shen You
Sen Zhang
Ming Ji
Nina Xue
Xiaoguang Chen
SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling
International Journal of Molecular Sciences
gastric cancer
SHMT2
HIF1α
redox balance
progression
title SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling
title_full SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling
title_fullStr SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling
title_full_unstemmed SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling
title_short SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling
title_sort shmt2 promotes gastric cancer development through regulation of hif1α vegf stat3 signaling
topic gastric cancer
SHMT2
HIF1α
redox balance
progression
url https://www.mdpi.com/1422-0067/24/8/7150
work_keys_str_mv AT weidawang shmt2promotesgastriccancerdevelopmentthroughregulationofhif1avegfstat3signaling
AT mingjinwang shmt2promotesgastriccancerdevelopmentthroughregulationofhif1avegfstat3signaling
AT tingtingdu shmt2promotesgastriccancerdevelopmentthroughregulationofhif1avegfstat3signaling
AT zhenyanhou shmt2promotesgastriccancerdevelopmentthroughregulationofhif1avegfstat3signaling
AT shenyou shmt2promotesgastriccancerdevelopmentthroughregulationofhif1avegfstat3signaling
AT senzhang shmt2promotesgastriccancerdevelopmentthroughregulationofhif1avegfstat3signaling
AT mingji shmt2promotesgastriccancerdevelopmentthroughregulationofhif1avegfstat3signaling
AT ninaxue shmt2promotesgastriccancerdevelopmentthroughregulationofhif1avegfstat3signaling
AT xiaoguangchen shmt2promotesgastriccancerdevelopmentthroughregulationofhif1avegfstat3signaling